Nervonik

Private

Los Angeles-based clinical-stage medical device company developing next-generation peripheral nerve stimulation systems that integrate stimulation with real-time biomarker sensing (ECAPs). Spun out of Dr. Aydin Babakhani's UCLA Electrical and Computer Engineering lab to bring personalized neuromodulation to chronic pain.

Founders Aydin Babakhani

CEO Aydin Babakhani

Company

Founded

2019

Headquarters

Los Angeles, United States

Financials

Total Funding

$66M

Sectors

Healthtech Hardware

nervonik.com

Funding History

2 rounds

Series B Apr 27, 2026

$53M

Amzak Health (Lead) Elevage Medical Technologies U.S. Venture Partners Lumira Ventures Foothill Ventures Shangbay Capital

Series A Mar 4, 2025

$13M

U.S. Venture Partners (Lead) Foothill Ventures Correlation Ventures

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.